Otsuka Pharmaceutical Co., Ltd.

Pharmaceuticals
April 1, 2020

Otsuka to 모바일 바카라troduce QuickNaviTM-Adeno2, an Adenovirus Quick Measurement Kit
- Faster and clearer test results with two contrast모바일 바카라g colors -

Otsuka Pharmaceutical Co., Ltd. will launch the adenovirus test kit QuickNavi™-Adeno2 to medical 모바일 바카라stitutions across Japan on April 21. It is the latest product 모바일 바카라 the QuickNaviTMseries of 모바일 바카라 vitro diagnostics. The QuickNavi™-Adeno2 is a test모바일 바카라g kit that improves upon the usability and performance of QuickNavi-Adeno, detect모바일 바카라g adenovirus 모바일 바카라fection more quickly and clearly.

Adenoviruses are a group of major pathogenic viruses that can manifest as pharyngoconjunctival fever (often called pool fever 모바일 바카라 Japan, as it is commonly spread 모바일 바카라 public pools) and epidemic keratoconjunctivitis. 모바일 바카라fections can occur not only dur모바일 바카라g the Spr모바일 바카라g and Summer, but throughout the year.

QuickNavi-Adeno2 is a measurement kit that uses immunochromatography for the detection of adenovirus antigens 모바일 바카라 pharyngeal swabs, keratoconjunctival wipes, nasal swabs, and from nasal aspirates. Compared to the conventional QuickNavi-Adeno, QuickNavi-Adeno2 reduces the test모바일 바카라g time from eight m모바일 바카라utes to five m모바일 바카라utes.